We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HQL
3551
abrdn Life Sciences Investors
HQL
$642M
$170K ﹤0.01%
11,946
-12,261
-51% -$185K
PBI icon
3552
Pitney Bowes
PBI
$2.27B
$170K ﹤0.01%
46,980
+2,939
+7% +$13.4K
RNGR icon
3553
Ranger Energy Services
RNGR
$401M
$170K ﹤0.01%
16,716
-9,131
-35% -$92K
LYTS icon
3554
LSI Industries
LYTS
$907M
$169K ﹤0.01%
27,422
+1,350
+5% +$8.66K
BSAC icon
3555
Banco Santander Chile
BSAC
$16.5B
$168K ﹤0.01%
+10,332
New +$201K
CXE
3556
DELISTED
MFS High Income Municipal Trust
CXE
$168K ﹤0.01%
44,770
+8,857
+25% +$35K
OPK icon
3557
Opko Health
OPK
$1.04B
$167K ﹤0.01%
66,095
+6,313
+11% +$18.4K
HGTY icon
3558
Hagerty
HGTY
$1.3B
$166K ﹤0.01%
14,429
+2,579
+22% +$26.1K
UTZ icon
3559
Utz Brands
UTZ
$1.25B
$166K ﹤0.01%
+12,043
New +$167K
ZIMV
3560
DELISTED
ZimVie
ZIMV
$165K ﹤0.01%
+10,282
New +$227K
ACCD
3561
DELISTED
Accolade Inc
ACCD
$164K ﹤0.01%
22,126
+1,974
+10% +$17.3K
BTAI icon
3562
BioXcel Therapeutics
BTAI
$28.8M
$163K ﹤0.01%
770
+86
+13% +$18.1K
FMY
3563
First Trust Mortgage Income Fund
FMY
$49.2M
$162K ﹤0.01%
13,876
-740
-5% -$8.74K
MORT icon
3564
VanEck Mortgage REIT Income ETF
MORT
$374M
$162K ﹤0.01%
11,552
ILPT
3565
Industrial Logistics Properties Trust
ILPT
$591M
$161K ﹤0.01%
11,441
-42
-0.4% -$689
OPP
3566
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$191M
$161K ﹤0.01%
14,992
+282
+2% +$3.13K
EMBJ
3567
Embraer S.A. ADS
EMBJ
$12.7B
$159K ﹤0.01%
18,134
-972
-5% -$10.4K
SG icon
3568
Sweetgreen
SG
$642M
$159K ﹤0.01%
13,647
-22,749
-63% -$480K
CRON
3569
Cronos Group
CRON
$1.13B
$158K ﹤0.01%
55,933
-32,571
-37% -$102K
MO icon
3570
CALL
Altria Group
MO
$109B
$158K ﹤0.01%
110,100
+96,700
+722% +$5.01M
HRZN icon
3571
Horizon Technology Finance
HRZN
$328M
$157K ﹤0.01%
13,564
-159
-1% -$1.99K
LAZR
3572
DELISTED
Luminar Technologies
LAZR
$157K ﹤0.01%
1,769
+153
+9% +$24.4K
CPRX
3573
DELISTED
Catalyst Pharmaceutical
CPRX
$156K ﹤0.01%
+22,324
New +$164K
WEA
3574
Western Asset Premier Bond Fund
WEA
$125M
$155K ﹤0.01%
14,672
-4,000
-21% -$44.6K
HTBK
3575
DELISTED
Heritage Commerce
HTBK
$154K ﹤0.01%
14,409
+2,582
+22% +$28.9K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.